#France #Qaelon Medical #RevMedica #Surgical Stapling #Strasbourg

Qaelon Medical and RevMedica: Enhancing Surgical Stapling Through Partnership

In a groundbreaking collaboration, Qaelon Medical, known for its innovative surgical leak detection solutions, has partnered with RevMedica, a forward-thinking company specializing in surgical stapling technologies. This partnership, announced on March 6, 2025, aims to improve clinical outcomes in gastrointestinal surgery by combining advanced technologies and data insights.

Objectives of the Partnership

This non-exclusive data partnership focuses on achieving several critical objectives:

1. Accelerated Product Development: By leveraging Qaelan’s leak detection technology alongside RevMedica’s stapler system, the companies plan to expedite the innovation cycle, ultimately providing new and improved surgical solutions soon.

2. Performance Assessment of Stapler Technologies: Understanding how tissue properties affect staple line performance will be paramount. This data will enable both companies to refine their products, ensuring better adaptability and success in diverse surgical scenarios.

3. Regulatory Support and Claims Development: The partnership will also help navigate the regulatory landscape more efficiently, aiding the approval of new devices and the substantiation of various performance claims.

Insights from Leadership

During the announcement, Thomas Wenchell, the CEO of RevMedica, expressed enthusiasm about the partnership noting, "Qaelon's leak detection technology offers RevMedica objective insights to enhance the development of our tissue sensing technology, ultimately improving clinical outcomes. We’re excited about the potential this partnership brings to establish new performance benchmarks."

Liam Burns, CEO of Qaelon Medical, highlighted the company's mission to tackle the serious issue of surgical leaks, stating, "Our collaboration with RevMedica expands the impact of our life-saving technology while building on the surgical intelligence platform with Caresyntax."

Advancements in Surgical Stapling

Integral to this partnership is RevMedica's new Endo Stapling Platform, which offers digital precision and real-time feedback during minimally invasive procedures. By optimizing staple formation and tissue management, this technology measurably enhances the efficiency and effectiveness of surgical practices.

Qaelon Medical's provision of real-time, quantifiable leak detection data further empowers surgeons. This immediate feedback allows for prompt corrective action, significantly shaping patient outcomes and reducing the likelihood of complications post-surgery.

Both companies' technologies are recognized under the FDA’s Safer Technologies Program (STeP), a program designed for medical devices that promise substantial safety improvements over existing options.

About Qaelon Medical

Qaelon Medical stands at the forefront of surgical technology by merging real-time leak detection with evolving surgical techniques. Their innovative platform is tailored to yield immediate feedback, enabling surgical teams to identify and rectify potential leaks before patients leave the operating room. This not only aims to enhance patient outcomes but also addresses the substantial costs associated with treating surgical leaks, which exceed $1.1 billion annually in the United States.

Utilizing state-of-the-art controls, digital sensors, and advanced software algorithms, Qaelon Medical redefines the landscape of surgical insufflation and leak assessment.

About RevMedica

Meanwhile, RevMedica is committed to transforming surgical approaches to soft tissue management. The company prioritizes cost-effective and environmentally sustainable practices, enhancing patient safety and optimizing clinical decision-making. Their focus lies in delivering cutting-edge technology that significantly improves surgical success rates while fostering broader sustainability in healthcare.

Both the platforms developed by Qaelon Medical and the products from RevMedica are currently still in development, with plans for future release under regulatory guidelines.

Through this partnership, Qaelon Medical and RevMedica are poised to make significant strides in surgical technology, driving enhanced safety and efficiency in operating rooms across the globe.